# JASCAYD
> **NDA220449** · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2025-12-19
## Drug
- **FDA Application Number:** NDA220449
- **Application type:** New Drug Application
- **Brand name:** JASCAYD
- **Generic name:** Nerandomilast
- **Active ingredients:** NERANDOMILAST
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BOEHRINGER INGELHEIM
- **First approval:** 2025-12-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220449)
---
*MORVS · CC0 1.0*